- Investing Ideas
- /
- South Korean Pharmaceuticals & Biotech Undervalued based on future growth
South Korean Pharmaceuticals & Biotech Undervalued based on future growth
Results
3
0 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
3 companies
Dong-A Socio Holdings
Market Cap: ₩634.2b
Engages in the pharmaceutical business in South Korea.
A000640
₩98,500.00
7D
0.4%
1Y
-9.7%
JW Pharmaceutical
Market Cap: ₩512.7b
Manufactures and sells medicines and medical supplies in Japan and internationally.
A001060
₩22,100.00
7D
0.5%
1Y
-27.3%
Daewon Pharmaceutical
Market Cap: ₩294.9b
A pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea.
A003220
₩13,760.00
7D
2.9%
1Y
-7.8%